Oxidative stress is a critical factor in the pathogenesis and progression of diabetes and its
associated complications. The imbalance between reactive oxygen species (ROS) …

Diabetic kidney disease (DKD) is a severe and common complication and affects a quarter
of patients with type 2 diabetes mellitus (T2DM). Oxidative stress and inflammation related to …

Background Oral semaglutide is the first glucagon-like peptide-1 receptor agonist (GLP-
1RA) designed for oral administration; it offers a promising opportunity to facilitate an early …

Background Hypertension and chronic kidney disease (CKD) pose significant public health
challenges, sharing intertwined pathophysiological mechanisms. Prediabetes is recognized …

Chronic kidney disease (CKD) is a condition characterized by the gradual loss of kidney
function over time and it is a worldwide health issue. The estimated frequency of CKD is …

Background Diabetic retinopathy (DR) is a common complication of diabetes. The
adipocytokines are closely associated with the occurrence and development of diabetes and …

Background The role of triglyceride-glucose (TyG) index, an insulin resistance indicator, in
glycemic management for diabetic patients with coronary artery disease (CAD) was still …

Background Distal symmetric polyneuropathy (DSPN) is a common microvascular
complication of both type 1 and 2 diabetes with substantial morbidity burden and reduced …

Purpose To systematically evaluate the effect of Sodium-glucose cotransporter 2 (SGLT2)
inhibitors on adipose tissue in patients with type 2 diabetes. Methods We searched PubMed …

Aims Diabetic kidney disease (DKD) is the one of the leading causes of end-stage kidney
disease. Unraveling novel biomarker signatures capable to identify patients with DKD is …